We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Tenet Healthcare (THC) Advances But Underperforms Market: Key Facts
Read MoreHide Full Article
Tenet Healthcare (THC - Free Report) closed at $129.64 in the latest trading session, marking a +0.14% move from the prior day. The stock fell short of the S&P 500, which registered a gain of 0.73% for the day. Elsewhere, the Dow gained 0.16%, while the tech-heavy Nasdaq added 0.98%.
The hospital operator's shares have seen a decrease of 9.87% over the last month, not keeping up with the Medical sector's loss of 3.8% and the S&P 500's gain of 0.34%.
Market participants will be closely following the financial results of Tenet Healthcare in its upcoming release. It is anticipated that the company will report an EPS of $2.93, marking a 9.33% rise compared to the same quarter of the previous year. Alongside, our most recent consensus estimate is anticipating revenue of $5.16 billion, indicating a 4.03% downward movement from the same quarter last year.
THC's full-year Zacks Consensus Estimates are calling for earnings of $11.37 per share and revenue of $20.76 billion. These results would represent year-over-year changes of +62.89% and +1.01%, respectively.
Investors should also take note of any recent adjustments to analyst estimates for Tenet Healthcare. Recent revisions tend to reflect the latest near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 0.05% decrease. As of now, Tenet Healthcare holds a Zacks Rank of #3 (Hold).
Digging into valuation, Tenet Healthcare currently has a Forward P/E ratio of 11.39. This valuation marks a premium compared to its industry's average Forward P/E of 11.37.
One should further note that THC currently holds a PEG ratio of 0.58. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. The Medical - Hospital industry currently had an average PEG ratio of 0.88 as of yesterday's close.
The Medical - Hospital industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 85, positioning it in the top 34% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Tenet Healthcare (THC) Advances But Underperforms Market: Key Facts
Tenet Healthcare (THC - Free Report) closed at $129.64 in the latest trading session, marking a +0.14% move from the prior day. The stock fell short of the S&P 500, which registered a gain of 0.73% for the day. Elsewhere, the Dow gained 0.16%, while the tech-heavy Nasdaq added 0.98%.
The hospital operator's shares have seen a decrease of 9.87% over the last month, not keeping up with the Medical sector's loss of 3.8% and the S&P 500's gain of 0.34%.
Market participants will be closely following the financial results of Tenet Healthcare in its upcoming release. It is anticipated that the company will report an EPS of $2.93, marking a 9.33% rise compared to the same quarter of the previous year. Alongside, our most recent consensus estimate is anticipating revenue of $5.16 billion, indicating a 4.03% downward movement from the same quarter last year.
THC's full-year Zacks Consensus Estimates are calling for earnings of $11.37 per share and revenue of $20.76 billion. These results would represent year-over-year changes of +62.89% and +1.01%, respectively.
Investors should also take note of any recent adjustments to analyst estimates for Tenet Healthcare. Recent revisions tend to reflect the latest near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 0.05% decrease. As of now, Tenet Healthcare holds a Zacks Rank of #3 (Hold).
Digging into valuation, Tenet Healthcare currently has a Forward P/E ratio of 11.39. This valuation marks a premium compared to its industry's average Forward P/E of 11.37.
One should further note that THC currently holds a PEG ratio of 0.58. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. The Medical - Hospital industry currently had an average PEG ratio of 0.88 as of yesterday's close.
The Medical - Hospital industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 85, positioning it in the top 34% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.